Reporting Manager
ADAR1 Capital Management, LLC
Symbol
IBIO
Shares outstanding
18,121,768 shares
Disclosed Ownership
1,794,055 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 21:13:11 UTC
Date of event
30 Jun 2025
Previous filing
14 Feb 2025
Next filing
17 Feb 2026

Quoteable Key Fact

"ADAR1 Capital Management, LLC disclosed 9.9% ownership in iBio, Inc. Common Stock, par value $0.001 per share (IBIO) on 30 Jun 2025."

Quick Takeaways

  • ADAR1 Capital Management, LLC filed SCHEDULE 13G/A for iBio, Inc. Common Stock, par value $0.001 per share (IBIO).
  • Disclosed ownership: 9.9%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 14 Feb 2025.
  • Current filing was accepted on 14 Aug 2025, 21:13.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ADAR1 Capital Management, LLC 9.9% 1,794,055 0 1,794,055 /s/ Daniel Schneeberger Daniel Schneeberger, Manager
ADAR1 Capital Management GP, LLC 9.9% 1,794,055 0 1,794,055 /s/ Daniel Schneeberger Daniel Schneeberger, Manager
Daniel Schneeberger 9.9% 1,794,055 0 1,794,055 /s/ Daniel Schneeberger Daniel Schneeberger, in his individual capacity
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .